Evidence map›Paper›PMID 41832535›Full record

SynthesisJournal of orthopaedic surgery and research2026

Single level versus multi-level lumbar interbody fusion for lumbar degenerative diseases: a systematic review and meta analysis.

Dana Ibrahim Alharbi, Waleed Osama Samarkandi, Leen Saleh Albraik, Layan Saleh Albraik, Muteb Nasser Alotaibi, Nasser Ahmad Alsaleh, Usman Salman Ali, Yaser Ali Alnafesh, Abdullah Hassan Latifah, Abdulrahman Alnwiji and 3 more

Abstract readSystematic ReviewMeta-AnalysisComparative Study
In one paragraph

Synthesis in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dana Ibrahim AlharbiCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Waleed Osama SamarkandiCollege of Medicine, AlMaarefa University, P.O. Box 71666, 11597, Riyadh, Saudi Arabia.
Leen Saleh AlbraikCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Layan Saleh AlbraikCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Muteb Nasser AlotaibiCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Nasser Ahmad AlsalehCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Usman Salman AliCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Yaser Ali AlnafeshCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Abdullah Hassan LatifahCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Abdulrahman AlnwijiCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Mohammed Omar AlamodiCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Raed A AlbarCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia.
Ayman Ma MohamedCollege of Medicine, Alfaisal University, 11533, Riyadh, Saudi Arabia. aymohamed@alfaisal.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDegenerative spondylolisthesis affects approximately 39 million patients worldwide. While consensus supports decompression with fusion for single-level pathology, optimal surgical approaches for multi-level disease remain disputed. Despite the frequency of this clinical presentation, evidence comparing outcomes between Single-Level versus Multi-Level interbody fusion procedures is surprisingly scarce. This study aims to determine how the level of interbody fusion extent impacts outcomes in patients undergoing lumbar fusion for degenerative spondylolisthesis.

methodsOur systematic review methodology involved comprehensive database searches (Web of Science, Scopus, PubMed, and Cochrane Library) from inception through April 2025. Two independent reviewers performed article screening, data extraction, and quality assessment. Statistical analyses used R software (v4.4.2), with outcomes reported as risk ratios for categorical variables and mean differences for continuous measures (95% CI). The certainty of evidence was assessed using the GRADE approach.

resultsOur meta-analysis evaluated 10 studies (N = 1430 patients; 971 Single-Level, 366 Double-Level, 198 Multi-Level fusions). Single-Level procedures demonstrated 41% lower revision rates (RR = 0.59 [0.40-0.86], p = 0.007). Operative advantages included reduced surgical time (-60.73 min [- 80.89 to - 40.57], p < 0.001), blood loss (-286.99mL [- 496.71 to - 77.27], p = 0.007), and hospitalization (-1.22 days [- 2.09 to - 0.34], p = 0.006). Oswestry Disability Index (ODI) scores showed borderline improvement (-3.90 [- 7.89 to 0.10], p = 0.06). Screw loosening decreased by 84% (RR = 0.16 [0.08-0.34], p < 0.001). We observed no significant differences in lumbar lordosis (-0.01 [- 1.75 to 1.72], p = 0.99), infection rates (RR = 0.49 [0.19-1.25], p = 0.13), adjacent segment deterioration, vascular injuries, or dural tears. The certainty of evidence ranged from low to very low, and high heterogeneity was observed in perioperative outcomes.

conclusionsSingle-level fusion may offer a more favorable perioperative profile than double- or multi-level constructs, including lower revision risk, shorter operative time, reduced blood loss, shorter hospitalization, and fewer screw loosening events in pooled analyses. However, complications did not differ significantly between groups. Given substantial heterogeneity for perioperative outcomes and generally low to very low certainty of evidence, these findings should be interpreted cautiously and individualized to patient pathology and surgical context.

Indexed as

Intervertebral Disc DegenerationLumbar VertebraeSpinal FusionSpondylolisthesisHumansTreatment OutcomeLIFLumbar fusionSingle levelSpondylolisthesis

Identifiers

PMID41832535
PMCPMC13104495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.